GPD1 and breast cancer: GPD1 expression has been found to be low in prostate, lung, and breast cancers [17, 18], and GPD1 was shown to have antitumor effects, which is consistent with our findings and predicts that GPD1 may be a potential therapeutic target in bladder cancer.